Resumo

ARIAS, Carlos et al. Glomerulonephritis due to minimal change disease post COVID-19 vaccine AstraZeneca. Rev. nefrol. dial. traspl. [online]. 2022, vol.42, n.1, pp.65-68. ISSN 2346-8548.

We report a case of a 28-year-old woman with minimal change disease secondary nephrotic syndrome 48 hours after the administration of the AstraZeneca SARS-CoV2 vaccine. The patient had suffered idiopathic nephrotic syndrome in childhood treated empirically with corticosteroids and cyclosporine, in complete remission from the age of 9. Some reports suggest that glomerular disease might appear infrequently associated to some vaccines.

Palavras-chave : coronavirus; severe acute respiratory syndrome; SARS-CoV-2; vaccination; minimal change nephrotic syndrome.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )